HEALTH CARE:
PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Neurocrine Biosciences Inc discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. The company's lead clinical development program, indiplon, is a drug for the treatment of insomnia.
Market Cap | 8.758 Billion | Shares Outstanding | 93.944 Million | Avg 30-day Volume | 948.078 Thousand | ||
P/E Ratio | 21.50348 | Dividend Yield | 0.0 | EPS | 4.16 | ||
Price/Sales | 9.84 | Debt to Equity | 1.54 | EBITDA | 336.1 Million | ||
Price to Book Value | 9.13 | Forward PE | 35.58 | Enterprise Value | 9.805 Billion | ||
Total Cash | 801 Million | Current Debt | 186.5 Million | Gross Profit | 1.036 Billion | ||
BETA | 0.79318 | 52-week High/Low | 136.26 / 72.14 | Next Earnings Date | 2021-02-04 | Price to Cash FLow (P/CF) | -9999999.0 |
Data provided by IEX Cloud |
Q4 2020 | All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|---|---|---|---|---|---|
In top 10: | 5 | 7 | -28.57% | 4 (0.24%) | 4 (0.25%) | 0.0% |
Funds Holding: | 387 | 404 | -4.21% | 104 (6.25%) | 122 (7.6%) | -14.75% |
13F shares: | 89.375 Million | 88.922 Million | 0.51% | 18.233 Million | 18.14 Million | 0.51% |
% Ownership | 95.6607 | 95.1762 | 0.51% | 19.5154 | 19.4154 | 0.52% |
New Positions: | 59 | 66 | -10.61% | 11 | 28 | -60.71% |
Increased Positions | 140 | 187 | -25.13% | 38 | 51 | -25.49% |
Closed Positions | 71 | 67 | 5.97% | 29 | 20 | 45.0% |
Reduced Positions | 147 | 107 | 37.38% | 46 | 34 | 35.29% |
Total Calls | 401.662 Thousand | 400.112 Thousand | 0.39% | 84.425 Thousand | 149.4 Thousand | -43.49% |
Total Puts | 1.213 Million | 1.366 Million | -11.22% | 357 Thousand | 379.8 Thousand | -6.0% |
PUT/CALL Ratio | 3.02 | 3.41 | -11.44% | 4.23 | 2.54 | 66.54% |
1 hedge funds and active managers as identified by whalewisdom.com through public filings. |
Please sign in first
none
422.5 Thousand total shares from 55 transactions
368.6 Thousand total shares from 14 transactions
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
LLOYD-SMITH MALCOLM CHIEF REGULATORY OFFICER |
|
32,510 | 2021-02-10 | 6 |
ABERNETHY MATT CHIEF FINANCIAL OFFICER |
|
27,912 | 2021-02-08 | 7 |
ROBERTS EIRY CHIEF MEDICAL OFFICER |
|
35,924 | 2021-02-08 | 6 |
GORMAN KEVIN CHARLES CHIEF EXECUTIVE OFFICER |
|
1,792,416 | 2021-02-05 | 5 |
BOZIGIAN HAIG P. CHIEF DEVELOPMENT OFFICER |
|
622,102 | 2021-02-05 | 5 |
GRIGORIADIS DIMITRI E. CHIEF RESEARCH OFFICER |
|
335,076 | 2021-02-05 | 7 |
GANO KYLE CHIEF BUSINESS DEVELOPMENT OFF |
|
509,582 | 2021-02-05 | 4 |
LIPPOLDT DARIN CHIEF LEGAL OFFICER |
|
129,893 | 2021-02-05 | 7 |
BENEVICH ERIC CHIEF COMMERCIAL OFFICER |
|
74,824 | 2021-02-05 | 7 |
COOKE JULIE CHIEF HUMAN RESOURCES OFFICER |
|
38,777 | 2021-02-05 | 5 |
|
223,697 | 2021-01-25 | 2 | |
|
27,055 | 2020-12-03 | 3 | |
|
0 | 2020-05-19 | 1 | |
|
0 | 2020-05-19 | 1 | |
|
0 | 2020-05-19 | 1 | |
|
0 | 2020-05-19 | 1 | |
|
0 | 2020-02-01 | 0 | |
|
0 | 2019-05-22 | 0 | |
|
0 | 2018-05-24 | 0 | |
OBRIEN CHRISTOPHER FLINT FORMER CHIEF MEDICAL OFFICER |
|
55,946 | 2018-02-05 | 0 |
|
0 | 2017-05-22 | 0 | |
COUGHLIN TIMOTHY P CHIEF FINANCIAL OFFICER |
|
137,961 | 2017-02-06 | 0 |
GROS DAVID-ALEXANDRE C PRESIDENT & COO |
|
0 | 2017-02-06 | 0 |
|
1,000 | 2015-06-23 | 0 | |
|
16,030 | 2015-04-07 | 0 | |
|
No longer subject to file | 2012-02-09 | 0 | |
VALEUR JENSEN MARGARET E EVP AND GENERAL COUNSEL |
|
0 | 2011-08-31 | 0 |
|
0 | 2011-05-25 | 0 | |
VENROCK HEALTHCARE CAPITAL PARTNERS LP |
|
4,784,689 | 2009-12-22 | 0 |
|
4,784,689 | 2009-12-22 | 0 | |
|
4,784,689 | 2009-12-22 | 0 | |
|
5,946,547 | 2009-01-22 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2021-02-12 20:27:14 -0500 | 2021-02-10 | S | 600 | $119.95 | d | 32,510 | direct | yes | ||||||||
2021-02-12 20:27:14 -0500 | 2021-02-10 | M | 1,100 | $35.99 | a | 33,610 | direct | |||||||||
2021-02-12 20:27:14 -0500 | 2021-02-10 | M | 600 | $35.99 | a | 33,110 | direct | |||||||||
2021-02-12 20:27:14 -0500 | 2021-02-10 | M | 1,700 | $35.99 | d | 21,533 | direct | |||||||||
2021-02-12 20:27:14 -0500 | 2021-02-10 | S | 1,100 | $119.96 | d | 32,510 | direct | yes | ||||||||
2021-02-09 21:16:10 -0500 | 2021-02-09 | S | 186 | $117.55 | d | 34,361 | direct | yes | ||||||||
2021-02-09 21:16:10 -0500 | 2021-02-09 | M | 30,000 | $35.99 | a | 64,361 | direct | |||||||||
2021-02-09 21:16:10 -0500 | 2021-02-09 | M | 36,194 | $35.99 | d | 0 | direct | |||||||||
2021-02-09 21:16:10 -0500 | 2021-02-09 | S | 6,008 | $116.21 | d | 34,361 | direct | yes | ||||||||
2021-02-09 21:16:10 -0500 | 2021-02-09 | M | 186 | $35.99 | a | 34,547 | direct | |||||||||
2021-02-09 21:16:10 -0500 | 2021-02-09 | M | 6,008 | $35.99 | a | 40,369 | direct | |||||||||
2021-02-09 21:16:10 -0500 | 2021-02-09 | S | 30,000 | $116.16 | d | 34,361 | direct | yes | ||||||||
2021-02-09 21:20:23 -0500 | 2021-02-08 | S | 1,015 | $116.87 | d | 32,510 | direct | yes | ||||||||
GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER |
2021-02-09 21:17:21 -0500 | 2021-02-08 | S | 4,343 | $116.74 | d | 450,051 | direct | yes | |||||||
2021-02-09 21:24:47 -0500 | 2021-02-08 | S | 913 | $116.72 | d | 13,737 | direct | yes | ||||||||
2021-02-09 21:16:10 -0500 | 2021-02-08 | A | 41,444 | a | 41,444 | direct | ||||||||||
2021-02-09 21:21:38 -0500 | 2021-02-08 | A | 7,439 | a | 7,439 | direct | ||||||||||
2021-02-09 21:21:38 -0500 | 2021-02-08 | S | 740 | $116.67 | d | 17,231 | direct | yes | ||||||||
2021-02-09 21:30:30 -0500 | 2021-02-08 | S | 2,030 | $116.81 | d | 14,869 | direct | yes | ||||||||
2021-02-09 21:16:10 -0500 | 2021-02-08 | S | 687 | $116.69 | d | 31,914 | direct | yes | ||||||||
2021-02-09 21:26:12 -0500 | 2021-02-08 | A | 44,632 | a | 44,632 | direct | ||||||||||
2021-02-09 21:18:48 -0500 | 2021-02-08 | A | 38,256 | a | 38,256 | direct | ||||||||||
2021-02-09 21:18:48 -0500 | 2021-02-08 | S | 687 | $116.67 | d | 83,456 | direct | yes | ||||||||
2021-02-09 21:26:12 -0500 | 2021-02-08 | S | 845 | $116.89 | d | 18,018 | direct | yes | ||||||||
2021-02-09 21:27:51 -0500 | 2021-02-08 | A | 3,188 | a | 3,188 | direct | ||||||||||
2021-02-09 21:42:22 -0500 | 2021-02-08 | A | 44,632 | a | 44,632 | direct | ||||||||||
2021-02-09 21:42:22 -0500 | 2021-02-08 | S | 1,070 | $116.89 | d | 102,406 | direct | yes | ||||||||
2021-02-09 21:27:51 -0500 | 2021-02-08 | S | 824 | $116.85 | d | 154,934 | direct | yes | ||||||||
2021-02-09 21:20:23 -0500 | 2021-02-08 | A | 5,314 | a | 5,314 | direct | ||||||||||
GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER |
2021-02-09 21:17:21 -0500 | 2021-02-08 | A | 103,609 | a | 103,609 | direct | |||||||||
2021-02-09 21:20:23 -0500 | 2021-02-08 | S | 1,490 | $116.74 | d | 31,597 | direct | yes | ||||||||
GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER |
2021-02-09 21:17:21 -0500 | 2021-02-08 | S | 2,875 | $116.79 | d | 446,144 | direct | yes | |||||||
2021-02-09 21:24:47 -0500 | 2021-02-08 | A | 5,314 | a | 5,314 | direct | ||||||||||
2021-02-09 21:24:47 -0500 | 2021-02-08 | S | 425 | $116.76 | d | 12,915 | direct | yes | ||||||||
2021-02-09 21:21:38 -0500 | 2021-02-08 | A | 44,632 | a | 44,632 | direct | ||||||||||
2021-02-09 21:30:30 -0500 | 2021-02-08 | A | 7,439 | a | 7,439 | direct | ||||||||||
2021-02-09 21:16:10 -0500 | 2021-02-08 | S | 1,522 | $116.72 | d | 34,361 | direct | yes | ||||||||
2021-02-09 21:30:30 -0500 | 2021-02-08 | S | 880 | $116.85 | d | 13,043 | direct | yes | ||||||||
2021-02-09 21:26:12 -0500 | 2021-02-08 | S | 2,030 | $116.84 | d | 21,099 | direct | yes | ||||||||
2021-02-09 21:18:48 -0500 | 2021-02-08 | S | 1,218 | $116.70 | d | 85,273 | direct | yes | ||||||||
2021-02-09 21:27:51 -0500 | 2021-02-08 | S | 1,623 | $116.79 | d | 157,651 | direct | yes | ||||||||
2021-02-09 21:42:22 -0500 | 2021-02-08 | S | 1,623 | $116.83 | d | 104,768 | direct | yes | ||||||||
2021-02-09 21:20:23 -0500 | 2021-02-08 | A | 31,880 | a | 31,880 | direct | ||||||||||
GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER |
2021-02-09 21:17:21 -0500 | 2021-02-08 | S | 3,248 | $116.72 | d | 452,972 | direct | yes | |||||||
2021-02-09 21:20:23 -0500 | 2021-02-08 | S | 756 | $116.89 | d | 30,437 | direct | yes | ||||||||
2021-02-09 21:24:47 -0500 | 2021-02-08 | A | 31,880 | a | 31,880 | direct | ||||||||||
2021-02-09 21:16:10 -0500 | 2021-02-08 | A | 6,908 | a | 6,908 | direct | ||||||||||
2021-02-09 21:21:38 -0500 | 2021-02-08 | S | 1,623 | $116.83 | d | 18,693 | direct | yes | ||||||||
2021-02-09 21:30:30 -0500 | 2021-02-08 | A | 44,632 | a | 44,632 | direct | ||||||||||
2021-02-09 21:16:10 -0500 | 2021-02-08 | S | 1,198 | $116.74 | d | 32,991 | direct | yes | ||||||||
2021-02-09 21:26:12 -0500 | 2021-02-08 | A | 7,439 | a | 7,439 | direct | ||||||||||
2021-02-09 21:18:48 -0500 | 2021-02-08 | A | 6,376 | a | 6,376 | direct | ||||||||||
2021-02-09 21:18:48 -0500 | 2021-02-08 | S | 803 | $116.69 | d | 84,178 | direct | yes | ||||||||
2021-02-09 21:26:12 -0500 | 2021-02-08 | S | 1,395 | $116.76 | d | 19,273 | direct | yes | ||||||||
2021-02-09 21:27:51 -0500 | 2021-02-08 | A | 532 | a | 532 | direct | ||||||||||
2021-02-09 21:42:22 -0500 | 2021-02-08 | A | 7,439 | a | 7,439 | direct | ||||||||||
2021-02-09 21:42:22 -0500 | 2021-02-08 | S | 1,000 | $116.83 | d | 103,306 | direct | yes | ||||||||
2021-02-09 21:27:51 -0500 | 2021-02-08 | S | 1,395 | $116.78 | d | 156,189 | direct | yes | ||||||||
GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER |
2021-02-09 21:17:21 -0500 | 2021-02-08 | A | 17,269 | a | 17,269 | direct | |||||||||
2021-02-09 21:20:23 -0500 | 2021-02-05 | S | 865 | $114.15 | d | 29,675 | direct | yes | ||||||||
2021-02-09 21:16:10 -0500 | 2021-02-05 | S | 605 | $114.05 | d | 30,627 | direct | yes | ||||||||
2021-02-09 21:18:48 -0500 | 2021-02-05 | S | 605 | $113.76 | d | 82,169 | direct | yes | ||||||||
2021-02-09 21:26:12 -0500 | 2021-02-05 | S | 809 | $114.03 | d | 16,434 | direct | yes | ||||||||
2021-02-09 21:42:22 -0500 | 2021-02-05 | S | 1,974 | $114.09 | d | 100,439 | direct | yes | ||||||||
2021-02-09 21:27:51 -0500 | 2021-02-05 | S | 704 | $113.79 | d | 153,328 | direct | yes | ||||||||
GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER |
2021-02-09 21:17:21 -0500 | 2021-02-05 | S | 2,422 | $114.16 | d | 443,249 | direct | yes | |||||||
2021-02-09 21:24:47 -0500 | 2021-02-05 | S | 605 | $113.86 | d | 12,125 | direct | yes | ||||||||
2021-02-09 21:42:22 -0500 | 2021-02-05 | S | 703 | $113.77 | d | 98,663 | direct | yes | ||||||||
2021-01-27 20:58:27 -0500 | 2021-01-26 | M | 300 | $41.78 | d | 56,223 | direct | |||||||||
2021-01-27 20:58:27 -0500 | 2021-01-26 | S | 300 | $120.00 | d | 15,805 | direct | yes | ||||||||
2021-01-27 21:30:34 -0500 | 2021-01-26 | M | 600 | $35.99 | a | 29,602 | direct | |||||||||
2021-01-27 21:53:04 -0500 | 2021-01-26 | S | 400 | $120.00 | d | 223,697 | direct | yes | ||||||||
2021-01-27 20:58:27 -0500 | 2021-01-26 | M | 300 | $41.78 | a | 16,105 | direct | |||||||||
2021-01-27 21:30:34 -0500 | 2021-01-26 | S | 500 | $119.96 | d | 29,002 | direct | yes | ||||||||
2021-01-27 20:58:27 -0500 | 2021-01-26 | S | 100 | $120.00 | d | 15,705 | direct | yes | ||||||||
2021-01-27 21:30:34 -0500 | 2021-01-26 | M | 1,100 | $35.99 | d | 23,233 | direct | |||||||||
2021-01-27 21:30:34 -0500 | 2021-01-26 | S | 600 | $119.98 | d | 29,002 | direct | yes | ||||||||
2021-01-27 21:30:34 -0500 | 2021-01-26 | M | 500 | $35.99 | a | 29,502 | direct | |||||||||
2021-01-27 20:58:27 -0500 | 2021-01-25 | S | 3,477 | $120.03 | d | 17,405 | direct | yes | ||||||||
2021-01-27 21:30:34 -0500 | 2021-01-25 | M | 8,958 | $32.99 | d | 0 | direct | |||||||||
2021-01-27 21:30:34 -0500 | 2021-01-25 | S | 8,958 | $119.95 | d | 29,002 | direct | yes | ||||||||
2021-01-27 21:30:34 -0500 | 2021-01-25 | M | 4,601 | $35.99 | a | 33,603 | direct | |||||||||
2021-01-27 20:58:27 -0500 | 2021-01-25 | M | 3,477 | $41.78 | d | 56,523 | direct | |||||||||
2021-01-27 20:58:27 -0500 | 2021-01-25 | M | 3,477 | $41.78 | a | 20,882 | direct | |||||||||
2021-01-27 21:30:34 -0500 | 2021-01-25 | M | 8,612 | $35.99 | d | 24,333 | direct | |||||||||
2021-01-27 21:30:34 -0500 | 2021-01-25 | M | 8,958 | $32.99 | a | 37,960 | direct | |||||||||
2021-01-27 21:30:34 -0500 | 2021-01-25 | S | 4,011 | $119.99 | d | 29,002 | direct | yes | ||||||||
2021-01-27 21:53:04 -0500 | 2021-01-25 | S | 1,600 | $120.03 | d | 224,097 | direct | yes | ||||||||
2021-01-27 20:58:27 -0500 | 2021-01-25 | S | 1,600 | $120.03 | d | 15,805 | direct | yes | ||||||||
2021-01-27 21:30:34 -0500 | 2021-01-25 | S | 4,601 | $119.98 | d | 29,002 | direct | yes | ||||||||
2021-01-27 21:30:34 -0500 | 2021-01-25 | M | 4,011 | $35.99 | a | 33,013 | direct | |||||||||
2021-01-12 16:17:59 -0500 | 2021-01-08 | S | 2,632 | $111.06 | d | 15,845 | direct | yes | 1.0541 | 6.3338 | 1.2575 | 10.4022 | 8 | -1.9695 | 13 | |
GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER |
2021-01-12 16:16:10 -0500 | 2021-01-08 | M | 143,449 | $8.66 | d | 0 | direct | ||||||||
GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER |
2021-01-12 16:16:10 -0500 | 2021-01-08 | S | 143,449 | $110.21 | d | 441,071 | direct | yes | 1.0541 | 6.3338 | 1.2575 | 10.4022 | 8 | -1.9695 | 13 |
GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER |
2021-01-12 16:16:10 -0500 | 2021-01-08 | S | 164,801 | $110.22 | d | 441,071 | direct | yes | 1.0541 | 6.3338 | 1.2575 | 10.4022 | 8 | -1.9695 | 13 |
GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER |
2021-01-12 16:16:10 -0500 | 2021-01-08 | M | 143,449 | $8.66 | a | 584,520 | direct | 1.0541 | 6.3338 | 1.2575 | 10.4022 | 8 | -1.9695 | 13 | |
GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER |
2021-01-12 16:16:10 -0500 | 2021-01-08 | M | 164,801 | $8.65 | d | 0 | direct | ||||||||
GORMAN KEVIN CHARLES - Director - Officer CHIEF EXECUTIVE OFFICER |
2021-01-12 16:16:10 -0500 | 2021-01-08 | M | 164,801 | $8.65 | a | 605,872 | direct | 1.0541 | 6.3338 | 1.2575 | 10.4022 | 8 | -1.9695 | 13 |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
NEUROCRINE BIOSCIENCES INC NBIX | 2021-03-08 22:15:03 UTC | -0.1804 | 0.2504 | 2400000 |
NEUROCRINE BIOSCIENCES INC NBIX | 2021-03-08 21:45:03 UTC | -0.1804 | 0.2504 | 2400000 |
NEUROCRINE BIOSCIENCES INC NBIX | 2021-03-08 21:15:03 UTC | -0.1804 | 0.2504 | 2400000 |
NEUROCRINE BIOSCIENCES INC NBIX | 2021-03-08 20:45:03 UTC | -0.1808 | 0.2508 | 2400000 |
NEUROCRINE BIOSCIENCES INC NBIX | 2021-03-08 20:15:03 UTC | -0.1808 | 0.2508 | 2400000 |
NEUROCRINE BIOSCIENCES INC NBIX | 2021-03-08 19:45:02 UTC | -0.1808 | 0.2508 | 2400000 |
NEUROCRINE BIOSCIENCES INC NBIX | 2021-03-08 19:15:02 UTC | -0.1808 | 0.2508 | 2400000 |
NEUROCRINE BIOSCIENCES INC NBIX | 2021-03-08 18:45:02 UTC | -0.1808 | 0.2508 | 2400000 |
NEUROCRINE BIOSCIENCES INC NBIX | 2021-03-08 18:15:02 UTC | -0.1808 | 0.2508 | 2400000 |
NEUROCRINE BIOSCIENCES INC NBIX | 2021-03-08 17:45:03 UTC | -0.1808 | 0.2508 | 2400000 |
NEUROCRINE BIOSCIENCES INC NBIX | 2021-03-08 17:15:03 UTC | -0.1808 | 0.2508 | 2400000 |
NEUROCRINE BIOSCIENCES INC NBIX | 2021-03-08 16:45:02 UTC | -0.1819 | 0.2519 | 2400000 |
NEUROCRINE BIOSCIENCES INC NBIX | 2021-03-08 16:15:03 UTC | -0.1819 | 0.2519 | 2400000 |
NEUROCRINE BIOSCIENCES INC NBIX | 2021-03-08 15:45:02 UTC | -0.1819 | 0.2519 | 2400000 |
NEUROCRINE BIOSCIENCES INC NBIX | 2021-03-08 15:15:03 UTC | -0.1819 | 0.2519 | 2400000 |
NEUROCRINE BIOSCIENCES INC NBIX | 2021-03-08 14:45:03 UTC | -0.18 | 0.25 | 2400000 |
NEUROCRINE BIOSCIENCES INC NBIX | 2021-03-08 14:15:03 UTC | -0.18 | 0.25 | 2400000 |
NEUROCRINE BIOSCIENCES INC NBIX | 2021-03-08 13:45:03 UTC | -0.18 | 0.25 | 2400000 |
NEUROCRINE BIOSCIENCES INC NBIX | 2021-03-08 13:15:03 UTC | -0.18 | 0.25 | 2400000 |
NEUROCRINE BIOSCIENCES INC NBIX | 2021-03-08 12:45:03 UTC | -0.18 | 0.25 | 2300000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
Calamos Investment Trust/IL- Calamos Market Neutral Income Fund | NBIX | -170371.0 shares, $-16810506.57 | 2020-10-31 | N-PORT |
AGF Investments Trust- AGFIQ U.S. Market Neutral Momentum Fund | NBIX | -244.0 shares, $-23387.4 | 2020-12-31 | N-PORT |
AQR Funds- AQR Large Cap Relaxed Constraint Equity Fund | NBIX | -250.0 shares, $-22527.5 | 2019-09-30 | N-PORT |
NORTHERN LIGHTS FUND TRUST II- Invenomic Fund | NBIX | -4393.0 shares, $-433457.31 | 2020-10-31 | N-PORT |
FundVantage Trust- Gotham Index Plus All-Cap Fund | NBIX | -4.0 shares, $-346.2 | 2020-03-31 | N-PORT |
AdvisorShares Trust- AdvisorShares Dorsey Wright Short ETF | NBIX | -3801.0 shares, $-364325.85 | 2020-12-31 | N-PORT |
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund | NBIX | -100.0 shares, $-9585.0 | 2020-12-31 | N-PORT |